Ocular Therapeutix (OCUL) Interest & Investment Income (2013 - 2026)

Ocular Therapeutix's Interest & Investment Income history runs 14 years deep, the most recent figure standing at $6.0 million for Q1 2026.

• In Q1 2026, Interest & Investment Income rose 58.13% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $20.6 million (up 1.94% YoY), while the FY2025 annual figure was $18.4 million, down 9.5% from the prior year.
• Interest & Investment Income was $6.0 million for Q1 2026 at Ocular Therapeutix, down from $7.3 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $7.3 million in Q4 2025 to a low of $18000.0 in Q1 2022.
• Historically, Interest & Investment Income has averaged $2.9 million across 5 years, with a median of $3.5 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Interest & Investment Income jumped 6950.0% in 2022, then tumbled 42.76% in 2025.
• A 5-year view of Interest & Investment Income shows it stood at $423000.0 in 2022, then jumped by 244.92% to $1.5 million in 2023, then soared by 220.15% to $4.7 million in 2024, then jumped by 57.2% to $7.3 million in 2025, then dropped by 17.61% to $6.0 million in 2026.
• The last three Interest & Investment Income figures came in at $6.0 million (Q1 2026), $7.3 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.